75 related articles for article (PubMed ID: 18999926)
1. XRCC1 polymorphism and lung cancer risk.
Schneider J; Classen V; Helmig S
Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926
[TBL] [Abstract][Full Text] [Related]
2. DNA repair genotype and lung cancer risk in the beta-carotene and retinol efficacy trial.
Doherty JA; Sakoda LC; Loomis MM; Barnett MJ; Julianto L; Thornquist MD; Neuhouser ML; Weiss NS; Goodman GE; Chen C
Int J Mol Epidemiol Genet; 2013; 4(1):11-34. PubMed ID: 23565320
[TBL] [Abstract][Full Text] [Related]
3. Loci identified through genome-wide association studies and lung cancer risk: is there anything more?
De Mello RA; Araújo A; Hespanhol V; Reis RM
Sao Paulo Med J; 2013; 131(2):135-6. PubMed ID: 23657518
[No Abstract] [Full Text] [Related]
4. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
[TBL] [Abstract][Full Text] [Related]
5. Association and multiple interaction analysis among five XRCC1 polymorphic variants in modulating lung cancer risk in North Indian population.
Singh A; Singh N; Behera D; Sharma S
DNA Repair (Amst); 2016 Nov; 47():30-41. PubMed ID: 27707541
[TBL] [Abstract][Full Text] [Related]
6. XRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis.
Qin CJ; Xu KW; Chen ZH; Zhai ET; He YL; Song XM
Tumour Biol; 2015 Feb; 36(2):461-6. PubMed ID: 25582318
[TBL] [Abstract][Full Text] [Related]
7. XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.
Wang G; Li Y; Pan R; Yin X; Jia C; She Y; Huang L; Yang G; Chi H; Tian G
Aging (Albany NY); 2024 Jan; 16(1):872-910. PubMed ID: 38217545
[TBL] [Abstract][Full Text] [Related]
8. Genetic Polymorphisms of ACE1 Rs4646994 Associated with Lung Cancer in Patients with Pulmonary Nodules: A Case-Control Study.
Qiao R; Sang S; Teng J; Zhong H; Li H; Han B
Biomedicines; 2023 May; 11(6):. PubMed ID: 37371643
[TBL] [Abstract][Full Text] [Related]
9. Survival association of XRCC1 for patients with head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Yang F; Zhou L; Chen J; Luo Y; Wang Y
Front Genet; 2022; 13():1035910. PubMed ID: 36685969
[No Abstract] [Full Text] [Related]
10. Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment.
Liu YP; Zheng CC; Huang YN; He ML; Xu WW; Li B
MedComm (2020); 2021 Sep; 2(3):315-340. PubMed ID: 34766149
[TBL] [Abstract][Full Text] [Related]
11. Association of PARP1-specific polymorphisms and haplotypes with non-small cell lung cancer subtypes.
Jin J; Robeson H; Fagan P; Orloff MS
PLoS One; 2020; 15(12):e0243509. PubMed ID: 33284833
[TBL] [Abstract][Full Text] [Related]
12. XRCC1 mediated the development of cervival cancer through a novel Sp1/Krox-20 swich.
Meng Q; Wang S; Tang W; Wu S; Gao N; Zhang C; Cao X; Li X; Zhang Z; Aschner M; Jin H; Huang Y; Chen R
Oncotarget; 2017 Oct; 8(49):86217-86226. PubMed ID: 29156789
[TBL] [Abstract][Full Text] [Related]
13. Regulation of therapeutic resistance in cancers by receptor tyrosine kinases.
Chen MK; Hung MC
Am J Cancer Res; 2016; 6(4):827-42. PubMed ID: 27186434
[TBL] [Abstract][Full Text] [Related]
14. DNA Repair Gene (XRCC1) Polymorphism (Arg399Gln) Associated with Schizophrenia in South Indian Population: A Genotypic and Molecular Dynamics Study.
Sujitha SP; Kumar DT; Doss CG; Aavula K; Ramesh R; Lakshmanan S; Gunasekaran S; Anilkumar G
PLoS One; 2016; 11(1):e0147348. PubMed ID: 26824244
[TBL] [Abstract][Full Text] [Related]
15. Association of DNA repair and xenobiotic pathway gene polymorphisms with genetic susceptibility to gastric cancer patients in West Bengal, India.
Ghosh S; Ghosh S; Bankura B; Saha ML; Maji S; Ghatak S; Pattanayak AK; Sadhukhan S; Guha M; Nachimuthu SK; Panda CK; Maity B; Das M
Tumour Biol; 2016 Jul; 37(7):9139-49. PubMed ID: 26768611
[TBL] [Abstract][Full Text] [Related]
16. Association of XRCC1 polymorphisms with thyroid cancer risk.
Wang C; Ai Z
Tumour Biol; 2014 May; 35(5):4791-7. PubMed ID: 24477575
[TBL] [Abstract][Full Text] [Related]
17. X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis.
Wang JY; Cai Y
Tumour Biol; 2014 Jan; 35(1):411-8. PubMed ID: 23943371
[TBL] [Abstract][Full Text] [Related]
18. A new era of allele-specific diagnostics?
Lustig AJ; Sgura A
Front Genet; 2013; 4():134. PubMed ID: 23882279
[No Abstract] [Full Text] [Related]
19. DNA repair gene XRCC3 Thr241Met polymorphism and hepatocellular carcinoma risk.
Duan C; Zhang W; Lu J; Wu H; Liu M; Zhu W
Tumour Biol; 2013 Oct; 34(5):2827-34. PubMed ID: 23824570
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of base-excision repair genes hOGG1 326cys and XRCC1 280His increase hepatocellular carcinoma risk.
Yuan T; Wei J; Luo J; Liu M; Deng S; Chen P
Dig Dis Sci; 2012 Sep; 57(9):2451-7. PubMed ID: 22565339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
